BD PHOENIX PANEL NMIC-306
Report
- Report Number
- 1119779-2022-00424
- Event Type
- Malfunction
- Date Received
- March 12, 2022
- Date of Event
- February 15, 2022
- Report Date
- April 18, 2022
- Manufacturer
- BECTON, DICKINSON & CO. (SPARKS)
- Product Code
- LON
- PMA / PMN Number
- SEE H10
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THE FOLLOWING FIELDS WERE UPDATED DUE TO ADDITIONAL INFORMATION: D9: DEVICE AVAILABLE FOR EVAL YES, D9: RETURNED TO MANUFACTURER ON: 21-FEB-2022. INVESTIGATION SUMMARY: THIS COMPLAINT IS FOR FALSE RESISTANT RESULTS OF ERTAPENEM (ETP) WITH KLEBSIELLA PNEUMONIAE, CITROBACTER KOSERI, AND ESCHERICHIA COLI WHEN USING PHOENIX PANEL NMIC-306 (449292) BATCH 1153290. THE CUSTOMER DID PROVIDE ISOLATES AND PANEL RETURNS FOR INVESTIGATION. TO INVESTIGATE, SEVEN CUSTOMER RETURNED PANELS WERE TESTED USING THE CUSTOMER RETURNED ISOLATES ON A PHOENIX 100 INSTRUMENT AND EVALUATED FOR ERTAPENEM (ETP) RESULTS. ONE PANEL WAS TESTED USING THE CUSTOMER'S KLEBSIELLA PNEUMONIAE ISOLATE, ONE PANEL WAS TESTED USING THE CUSTOMER'S ISOLATE OF CITROBACTER KOSERI, AND ONE PANEL WAS TESTED PER EACH STRAIN OF ESCHERICHIA COLI (5) FOR A TOTAL OF SEVEN PANELS TESTED. DURING INVESTIGATION, ALL SEVEN PANELS YIELDED SATISFACTORY ERTAPENEM (ETP) RESULTS WITHIN THE SPECIFIED RANGES. DUE TO THE SATISFACTORY RESULTS, THIS COMPLAINT IS NOT CONFIRMED. A REVIEW OF QUALITY NOTIFICATIONS REVEALED NO QUALITY NOTIFICATIONS FOR THIS COMPLAINT BATCH. A REVIEW OF COMPLAINTS REVEALED NO ADDITIONAL COMPLAINTS FOR THIS COMPLAINT BATCH. COMPLAINT TRENDING WAS PERFORMED AND NO TRENDS WERE IDENTIFIED ASSOCIATED WITH THIS DEFECT. BD ID/AST PLANT QUALITY WILL CONTINUE TO MONITOR FOR TRENDS AND TAKE ACTION AS NECESSARY.
THE BD PHOENIX NMIC-306 IS AN ANTIMICROBIAL RESISTANCE PANEL THAT CONSISTS OF A COMBINATION OF THE FOLLOWING 510K NUMBERS:, K032299, K061355, K061327, K031912, K023444, K063824, K033560, K063573, K041384, K060217, K052269, K181665, K190905, K032655, K062944, K060444, K173252, K033362, K062207, K063811, K163637, K151320, K063301, K031530, K032567, K060257, K023634, K020322, K132674, K173523, K063486, K022129, K023858, K071623, K031699, K060447, K024153, K060214, K132909, K042932. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.
IT WAS REPORTED THAT WHILE TESTING WITH THE BD PHOENIX PANEL NMIC-306, ABOUT 10 FALSE RESISTANT RESULTS WERE OBTAINED. REPEAT TESTING WAS PERFORMED AND THE RESULTS WERE SENSITIVE. THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: MIC DISCREPANCY (EXPECTED: ERTAPENEM INITIALLY REPORTING RESISTANT; ACTUAL: ERTAPENEM ARE REPEATING SUSCEPTIBLE. CUSTOMER REPORTS FALSE RESISTANCE WITH ERTAPENEM WHEN USING 449292 - LOT #1153290. ABOUT TEN SAMPLES WERE AFFECTED. INITIALLY THE P100 RESULTED ERTAPENEM AS RESISTANT BUT WERE FOUND TO BE SENSITIVE AFTER REPEATING ON THE SAME P100.
IT WAS REPORTED THAT WHILE TESTING WITH THE BD PHOENIX PANEL NMIC-306, ABOUT 10 FALSE RESISTANT RESULTS WERE OBTAINED. REPEAT TESTING WAS PERFORMED AND THE RESULTS WERE SENSITIVE. THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: MIC DISCREPANCY (EXPECTED: ERTAPENEM INITIALLY REPORTING RESISTANT; ACTUAL: ERTAPENEM ARE REPEATING SUSCEPTIBLE CUSTOMER REPORTS FALSE RESISTANCE WITH ERTAPENEM WHEN USING 449292 - LOT #1153290. ABOUT TEN SAMPLES WERE AFFECTED. INITIALLY THE P100 RESULTED ERTAPENEM AS RESISTANT BUT WERE FOUND TO BE SENSITIVE AFTER REPEATING ON THE SAME P100.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 972630 | BD PHOENIX PANEL NMIC-306 | SYSTEM, TEST, AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY | LON | BECTON, DICKINSON & CO. (SPARKS) | 1153290 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown |